Compare ALTO & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTO | TOI |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Major Chemicals | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.4M | 304.4M |
| IPO Year | 2005 | N/A |
| Metric | ALTO | TOI |
|---|---|---|
| Price | $4.95 | $3.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $917,927,000.00 | N/A |
| Revenue This Year | $6.66 | $30.15 |
| Revenue Next Year | $0.43 | $25.77 |
| P/E Ratio | $30.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.80 | $2.02 |
| 52 Week High | $5.25 | $4.88 |
| Indicator | ALTO | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 59.40 |
| Support Level | $0.98 | $3.35 |
| Resistance Level | $5.07 | $3.74 |
| Average True Range (ATR) | 0.30 | 0.20 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 69.23 | 65.22 |
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.